Double Blind Study on the Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids.
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
A Randomized Phase 2 double blind study which aims to determine the safety and efficacy of
CITI-002 cream in adult patients with Goligher's grade II or III hemorrhoids.